ArticleHealth science reports2026
A Real-Time Mobile AI-Assisted System for Skin Disease Prescreening: A Technical Feasibility Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Skin diseases remain a widespread health concern, particularly in areas where access to dermatological care is limited. With the growing availability of smartphones and advances in deep learning, mobile-based image analysis offers a practical option for early-stage screening. This study aims to develop and evaluate a lightweight, real-time mobile AI-assisted system for skin disease prescreening on Android devices. Methods: An Android application, SkinLearn, was developed by integrating a YOLO11-based image classification model optimized for on-device inference using TensorFlow Lite. The model was trained on a publicly available seven-class skin disease dataset and further evaluated on the PAD-UFES-20 skin cancer dataset to examine its ability to generalize across datasets. A YOLOv8 model was also implemented under the same conditions for comparison. Results: The proposed YOLO11 model achieved a top-1 accuracy of 99.2% on the seven-class dataset and 71.4% on the PAD-UFES-20 dataset, outperforming the YOLOv8 baseline in both cases. The mobile implementation enabled real-time, offline inference with low computational overhead, demonstrating efficient deployment in resource-constrained environments. However, the observed performance drop across datasets highlights challenges related to domain shift, class imbalance, and variability in imaging conditions. Conclusion: These findings support the technical feasibility of lightweight deep learning models such as YOLO11 for accessible mobile skin disease prescreening. However, the observed performance drop on PAD-UFES-20 indicates that further validation across more diverse datasets and clinical settings is needed before any real-world clinical use is considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.